Skip to main content

AMR 2024 Symposium: Integrated Approaches to Predict and Prevent AMR Pandemics, May 21-22

Written by cida on .

Register here

TUESDAY MAY 21

Session 1: AMR Education and Communication

“Breaking Down Barriers to Sustainable Antimicrobial Use in Cats”Amelia Greiner Safi and Casey Cazer”Influences of scientific storytelling and visual narratives on antimicrobial resistance”Meghan McGillin and Megan Keller“Bridging borders, battling bacteria: The UK’s AMR National Action Plan and its international efforts across research, policy, and education” Garrett DunlapSession Keynote

“All the mutants we could not see: Deep mutagenesis of antibiotic binding-site”

Dr. Aviram Rasouly, Senior Research Scientist, New York University & Howard Hughes Medical Institute

WEDNESDAY MAY 22

Session 2: Detection, Discovery and Delivery

“integrated phenotypic and activity-based profiling of electrophilic fragments reveals new druggable targets for antibiotics development”Mikail Abbasov“Antimicrobial resistance in the Fire Blight pathogen Erwinia amylovora: More than 10 years of Research Discoveries, Commercial Detection, and Extension Deliverables”Kerik Cox“Delivering antibiotics across the eardrum by harnessing immune cells”​​​​​​​​​​​​​​Rong Yang”From the soil to the clinic, towards an understanding of triclosan resistance in Stenotrophomonas species”​​​​​​​​​​​​​​Anthony Hay“RNA liquid biopsy for infectious disease”​​​​​​​​​​​​​​Iwijn De Vlaminck“Detection of β-lactam resistance in staphylococci: it’s enough to mec you crazy”​​​​​​​​​​​​​​Lars WestbladeSession 3: Origins and Mechanisms of Resistance and Tolerance

“Heightened sensitivity to β-lactam antibiotics due to metabolic dysregulation”​​​​​​​​​​​​​​John Helmann“Incorporating resilience to antimicrobial resistance in early drug discovery efforts”​​​​​​​​​​​​​​Brian VanderVen“The role of lipid A-modifying phosphoethanolamine transferases in polymyxin resistance”​​​​​​​​​​​​​​Anna Schumann“Understanding salmonella capsule variations: Impact on virulence and intervention strategies”​​​​​​​​​​​​​​Gi Young Lee“From Commensal to pathogen: Role of enterococcal metabolic programming during surface penetration​​​​​​​​​​​​​​Diana Morales​​​​​​​Session Keynote

“Phenotypic screening approaches for discovering mechanistically novel antibiotic leads to combat AMR”

Dr. Terry Roemer, Chair and Chief Scientific Officer, Prokaryotics, Inc.